This site uses cookies to bring you the best experience. Find out more
Skip to main content

Discover our world-class facilities

Designed to support innovation and expansion, The Oxford Science Park offers exceptional lab and office space for science and technology businesses of all sizes.

Discover the park

 

LATEST NEWS

Boehringer Ingelheim licenses novel oral therapeutics program from Sitryx Therapeutics

27 . 02 . 26

Boehringer has acquired an exclusive license for a preclinical, small molecule program from Sitryx,  a clinical-stage biopharmaceutical company developing novel oral therapies to restore immune balance in autoimmune and inflammatory diseases, based...

Read More